Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaëtan MacGrogan

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 23, 2018
Solid papillary carcinoma with reverse polarity of the breast harbors specific morphologic, immunohistochemical and molecular profile in comparison with other benign or malignant papillary lesions of the breast: a comparative study of 9 additional casesNadjla Alsadoun, Gaëtan MacGrogan, Caroline Truntzer, et al.
Plos One|January 4, 2013
Deletion of chromosomes 13q and 14q is a common feature of tumors with BRCA2 mutationsAudrey Rouault, Guillaume Banneau, Gaëtan Macgrogan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 23, 2021
Triple-negative breast lobular carcinoma: a luminal androgen receptor carcinoma with specific ESRRA mutationsAnthony Bergeron, Gaëtan MacGrogan, Aurélie Bertaut, et al.
Cancer Research|September 28, 2013
CD95L cell surface cleavage triggers a prometastatic signaling pathway in triple-negative breast cancerMarine Malleter, Sébastien Tauzin, Alban Bessede, et al.
Cancer Research|February 5, 2020
Correction: CD95L Cell Surface Cleavage Triggers a Prometastatic Signaling Pathway in Triple-Negative Breast CancerMarine Malleter, Sébastien Tauzin, Alban Bessede, et al.
Cancer Genetics|March 9, 2022
PTEN alterations in sporadic and BRCA1-associated triple negative breast carcinomasNatalie Jones, Audrey Gros, Valérie Velasco, et al.
Annals of Surgical Oncology|March 18, 2015
The Role of Sentinel Lymph Node Biopsy and Factors Associated with Invasion in Extensive DCIS of the Breast Treated by Mastectomy: The Cinnamome Prospective Multicenter StudyChristine Tunon-de-Lara, Marie Pierre Chauvet, Marie Christine Baranzelli, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 20, 2019
Ovarian Clear Cell Carcinoma in Cowden SyndromeKevin Yauy, Marion Imbert-Bouteille, Virginie Bubien, et al.
BMC Medical Genomics|November 29, 2012
An array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosisFrançoise Bonnet, Mickael Guedj, Natalie Jones, et al.
Breast Cancer Research : BCR|August 18, 2010
Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutationsGuillaume Banneau, Mickaël Guedj, Gaëtan MacGrogan, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 23, 2018
Solid papillary carcinoma with reverse polarity of the breast harbors specific morphologic, immunohistochemical and molecular profile in comparison with other benign or malignant papillary lesions of the breast: a comparative study of 9 additional casesNadjla Alsadoun, Gaëtan MacGrogan, Caroline Truntzer, et al.
Plos One|January 4, 2013
Deletion of chromosomes 13q and 14q is a common feature of tumors with BRCA2 mutationsAudrey Rouault, Guillaume Banneau, Gaëtan Macgrogan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 23, 2021
Triple-negative breast lobular carcinoma: a luminal androgen receptor carcinoma with specific ESRRA mutationsAnthony Bergeron, Gaëtan MacGrogan, Aurélie Bertaut, et al.
Cancer Research|September 28, 2013
CD95L cell surface cleavage triggers a prometastatic signaling pathway in triple-negative breast cancerMarine Malleter, Sébastien Tauzin, Alban Bessede, et al.
Cancer Research|February 5, 2020
Correction: CD95L Cell Surface Cleavage Triggers a Prometastatic Signaling Pathway in Triple-Negative Breast CancerMarine Malleter, Sébastien Tauzin, Alban Bessede, et al.
Cancer Genetics|March 9, 2022
PTEN alterations in sporadic and BRCA1-associated triple negative breast carcinomasNatalie Jones, Audrey Gros, Valérie Velasco, et al.
Annals of Surgical Oncology|March 18, 2015
The Role of Sentinel Lymph Node Biopsy and Factors Associated with Invasion in Extensive DCIS of the Breast Treated by Mastectomy: The Cinnamome Prospective Multicenter StudyChristine Tunon-de-Lara, Marie Pierre Chauvet, Marie Christine Baranzelli, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 20, 2019
Ovarian Clear Cell Carcinoma in Cowden SyndromeKevin Yauy, Marion Imbert-Bouteille, Virginie Bubien, et al.
BMC Medical Genomics|November 29, 2012
An array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosisFrançoise Bonnet, Mickael Guedj, Natalie Jones, et al.
Breast Cancer Research : BCR|August 18, 2010
Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutationsGuillaume Banneau, Mickaël Guedj, Gaëtan MacGrogan, et al.
Pageof 8